PRCT
PROCEPT BioRobotics Corporation (NASDAQ)
Healthcare — Medical Devices
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Price History
Fundamentals
| Market Cap | $1.34B |
| P/E Ratio (TTM) | - |
| Forward P/E | -26.98 |
| EPS (TTM) | $-1.83 |
| Dividend Yield | - |
| Profit Margin | -31.82% |
| Revenue Growth | 20.20% |
| ROE | -27.82% |
| Debt/Equity | 22.43 |
| Recommendation | Buy 2.1 |
| Analyst Target | $30.20 |
| Analysts | 10 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 28.4 |
| Beta | 0.85 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $62.17 |
| 52-Week Low | $19.35 |
| 50-Day Avg | $25.18 |
| 200-Day Avg | $29.34 |
| Avg Volume | $1.63M |
| Volume | 563.9K |
Performance Analysis
BULLISHPRCT shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:27 UTC
Back to Screener Export Report